The purpose of this study is to determine whether NeoVIDERM is effective at preventing radiation dermatitis in patients receiving external beam radiation therapy to the head and neck or breast areas.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
14
Twice a day
Twice a day, when there is dry desquamation
Three times a day
Jewish General Hospital
Montreal, Quebec, Canada
Maximum skin toxicity
The objective of this study is to determine the occurrence and degree of acute skin toxicity in patients receiving radical radiation therapy with preventive application of neoVIDERM compared to patients treated with institutional standard skin care.
Time frame: 7 weeks post beginning of radiation treatments
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.